Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Cytokines and cancer cachexia

¹University of Texas, Dallas.

Hospital Practice (Office Ed.)

|April 15, 1993

Summary

This summary is machine-generated.

Cachexia, a cancer by-product, is mediated by cytokines like tumor necrosis factor (TNF). Future treatments may involve blocking TNF activity with specific reagents.

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Heterozygous mis-sense mutations in Prkcb as a critical determinant of anti-polysaccharide antibody formation.

Genes and immunity·2013

Same author

Massively parallel sequencing of the mouse exome to accurately identify rare, induced mutations: an immediate source for thousands of new mouse models.

Open biology·2012

Same author

Protein-energy malnutrition halts hemopoietic progenitor cells in the G0/G1 cell cycle stage, thereby altering cell production rates.

Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas·2009

Same author

The forward genetic dissection of afferent innate immunity.

Current topics in microbiology and immunology·2008

Same author

Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin. Science, 1985, 229(4716):869-871. Classical article.

Journal of immunology (Baltimore, Md. : 1950)·2008

Same author

TLR signaling pathways: opportunities for activation and blockade in pursuit of therapy.

Current pharmaceutical design·2006

Area of Science:

Biochemistry
Oncology
Immunology

Background:

Cachexia is a complex metabolic syndrome.
It is associated with cancer, chronic diseases, and trauma.
Cytokines are implicated in cachexia pathogenesis.

Purpose of the Study:

To identify key mediators of cachexia.
To explore potential therapeutic targets for cachexia.

Main Methods:

Identification of cytokines involved in cachexia.
Utilizing molecular cloning techniques.

Main Results:

Tumor necrosis factor (TNF) identified as a principal mediator of cachexia.
Demonstrated the role of cytokines in disease progression.

Conclusions:

Cachexia pathogenesis involves cytokine signaling.
Targeting TNF activity presents a promising therapeutic strategy.
Molecular cloning enables the development of specific anti-TNF reagents.